These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 33752389)
1. [Early and concurrent therapy of dyslipidemia and hypertension: when to start it and how to maintain patient´s good and long-term adherence?]. Soška V Vnitr Lek; 2021; 67(1):37-40. PubMed ID: 33752389 [TBL] [Abstract][Full Text] [Related]
2. [News in the treatment of hypertension and dyslipidemia]. Václavík J Vnitr Lek; 2017; 63(5):333-337. PubMed ID: 28726432 [TBL] [Abstract][Full Text] [Related]
3. [How to create cooperative patient for antihypertensive and hypolipidemic therapy]. Piťha J Vnitr Lek; 2017; 63(4):272-276. PubMed ID: 28520451 [TBL] [Abstract][Full Text] [Related]
4. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome. Ferdinand KC J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832 [TBL] [Abstract][Full Text] [Related]
5. The evening versus morning polypill utilization study: the TEMPUS rationale and design. Lafeber M; Grobbee DE; Bots ML; Thom S; Webster R; Rodgers A; Visseren FL; Spiering W Eur J Prev Cardiol; 2014 Apr; 21(4):425-33. PubMed ID: 23382539 [TBL] [Abstract][Full Text] [Related]
6. [Dyslipidemia and hypertension - what to worry about more?]. Václavík J Vnitr Lek; 2018; 64(4):395-401. PubMed ID: 29791175 [TBL] [Abstract][Full Text] [Related]
7. The role of statins in endothelial dysfunction in hypertension. Sarkar K; Sinha AK; Mehta JL Curr Opin Cardiol; 2006 Jul; 21(4):316-21. PubMed ID: 16755200 [TBL] [Abstract][Full Text] [Related]
8. [Hypertension and dyslipidemia treament in stroke]. Nussbaumerová B Vnitr Lek; 2022; 68(3):172-177. PubMed ID: 36208947 [TBL] [Abstract][Full Text] [Related]
9. Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives. Devabhaktuni M; Bangalore S Vasc Health Risk Manag; 2009; 5(1):377-87. PubMed ID: 19475775 [TBL] [Abstract][Full Text] [Related]
10. Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective? Grover S; Coupal L; Lowensteyn I Can J Cardiol; 2008 Dec; 24(12):891-8. PubMed ID: 19052668 [TBL] [Abstract][Full Text] [Related]
11. Statins in hypertension: are they a new class of antihypertensive agents? Feldstein CA Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164 [TBL] [Abstract][Full Text] [Related]
12. [Notes on the HOPE-3 study]. Soška V Vnitr Lek; 2016; 62(11):929-932. PubMed ID: 28128582 [TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study. Kaasenbrood L; Poulter NR; Sever PS; Colhoun HM; Livingstone SJ; Boekholdt SM; Pressel SL; Davis BR; van der Graaf Y; Visseren FL; Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):213-21. PubMed ID: 27174798 [TBL] [Abstract][Full Text] [Related]
14. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis. Weisser B; Predel HG; Gillessen A; Hacke C; Vor dem Esche J; Rippin G; Noetel A; Randerath O High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):157-164. PubMed ID: 32219670 [TBL] [Abstract][Full Text] [Related]
15. Secondary prevention advices after cardiovascular index event: From drug prescription to risk factors control in real world practice. Faggiano P; Fattirolli F; Frisinghelli A; Piccioli L; Dasseni N; Silverii MV; Albricci L; D'Ambrosio G; Garrì R; Esposito L; Giallauria F Monaldi Arch Chest Dis; 2019 May; 89(2):. PubMed ID: 31107039 [TBL] [Abstract][Full Text] [Related]
16. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care. Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A BMJ; 2014 May; 348():g3318. PubMed ID: 24868083 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease. Poussa H; Strandberg TE; Tikkanen I; Kauhanen P; Lepäntalo M Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761 [TBL] [Abstract][Full Text] [Related]
18. Analysis of incidence and prevalence of cardiovascular risk factors and evaluation of their control in epidemiological survey in the Czech Republic. Chmelík Z; Vaclová M; Lánská V; Laštůvka J; Vrablík M Cent Eur J Public Health; 2020 Jun; 28(2):114-119. PubMed ID: 32592555 [TBL] [Abstract][Full Text] [Related]
19. [Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data]. Šnejdrlová M; Češka R; Janíčková-Žďárská D; Honěk P; Dušek P; Pavlík T; Kvapil M Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S30-7. PubMed ID: 26652963 [TBL] [Abstract][Full Text] [Related]
20. Combined antihypertensive and statin therapy for the prevention of cardiovascular events in patients with hypertension without complications: protocol for a systematic review and meta-analysis. Wang Y; Kuang ZM; Feng SJ; Jiang L; Chen QX; Ji XY; Cheng WL; Hu HJ BMJ Open; 2018 May; 8(5):e019719. PubMed ID: 29858408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]